Senator Josh Hawley has recently raised concerns about the growing relationship between China and the United States in terms of drug trade. In a recent statement, he referred to China as America's sweetheart drug dealer, warning that this relationship poses a clear and present danger to the country. The senator's concerns are not unfounded. China has long been known as a major source of illicit drugs, including fentanyl, a powerful synthetic opioid responsible for a significant portion of overdose deaths in the United States. In fact, according to the Drug Enforcement Administration (DEA), China is the primary source of fentanyl and fentanyl-related substances in the United States. China's role in the drug trade is not limited to fentanyl, however. The country is also a major source of other illicit drugs, including methamphetamine and cocaine. In recent years, Chinese drug trafficking organizations have become increasingly sophisticated, using advanced technology and international networks to smuggle drugs into the United States. Senator Hawley's concerns about the relationship between China and the United States are not limited to drug trade, either. He has also raised concerns about China's growing influence in other areas, including technology and national security. In particular, he has been a vocal critic of Chinese telecom giant Huawei, which he has accused of posing a threat to national security. The senator's warnings about China's drug trade are particularly timely, given the ongoing opioid epidemic in the United States. According to the Centers for Disease Control and Prevention (CDC), more than 70,000 Americans died from drug overdoses in 2019, with opioids accounting for the majority of those deaths. While there is no easy solution to the opioid epidemic, addressing the role of China in the drug trade is an important step. This will require cooperation between the United States and China, as well as increased efforts to disrupt drug trafficking networks and improve addiction treatment and prevention programs. In the meantime, Senator Hawley's warnings about the dangers of America's sweetheart drug deals with China should serve as a wake-up call to policymakers and the public alike. The opioid epidemic is a national crisis, and addressing it will require a concerted effort from all stakeholders.